Werbung
Werbung

PRVA

PRVA logo

Privia Health Group, Inc. Common Stock

23.10
USD
Gesponsert
-1.10
-4.53%
08. Jan., 14:41 UTC -5
Offen

PRVA Ergebnisberichte

Positives Überraschungsverhältnis

PRVA übertreffen die 9 der letzten 19Schätzungen.

47%

Nächster Bericht

Datum des nächsten Berichts
25. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$838.94M
/
$0.03
Implizierte Änderung von Q3 25 (Revenue/ EPS)
-10.79%
/
-40.00%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+5.86%
/
--

Privia Health Group, Inc. Common Stock earnings per share and revenue

On 06. Nov. 2025, PRVA reported earnings of 0.05 USD per share (EPS) for Q3 25, missing the estimate of 0.05 USD, resulting in a -8.93% surprise. Revenue reached 940.40 million, compared to an expected 797.58 million, with a 17.91% difference. The market reacted with a -4.16% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 21 analysts forecast an EPS of 0.03 USD, with revenue projected to reach 838.94 million USD, implying an decrease of -40.00% EPS, and decrease of -10.79% in Revenue from the last quarter.
FAQ
For Q3 2025, Privia Health Group, Inc. Common Stock reported EPS of $0.05, missing estimates by -8.93%, and revenue of $940.40M, 17.91% above expectations.
The stock price moved down -4.16%, changed from $25.02 before the earnings release to $23.98 the day after.
The next earning report is scheduled for 25. Feb. 2026.
Based on 21 analysts, Privia Health Group, Inc. Common Stock is expected to report EPS of $0.03 and revenue of $838.94M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung